Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer

NCT04003246 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Lung Cancer Stage III

Interventions

RADIATION: Thoracic RT and Durvalumab
DRUG: Consolidative Durvalumab

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]